The Economic Burden of Chronic Cardiovascular Disease for Major Insurers

Abstract

Accounting models provide less precise estimates of disease burden than do econometric models. The authors seek to improve these estimates for cardiovascular disease using a nationally representative survey and econometric modeling to isolate the proportion of medical expenditures attributable to four chronic cardiovascular diseases: stroke, hypertension, congestive heart failure, and other heart diseases. Approximately 17% of all medical expenditures, or $149 billion annually, and nearly 30% of Medicare expenditures are attributable to these diseases. Of the four diseases, hypertension accounts for the largest share of prescription expenditures across payers and the largest share of all Medicaid expenditures. The large number of people with cardiovascular disease who are eligible for both Medicare and Medicaid could lead to large shifts in the burden to these payers as prescription drug coverage is included in Medicare. A societal perspective is important when describing the economic burden of cardiovascular disease.

Keywords

medical expenditures econometric model cost estimation cardiovascular disease stroke hypertension congestive heart failure heart diseases Medicaid Medicare insurer

Get full access to this article

View all access options for this article.

References

Akobundu, E. , Ju, J. , Blatt, L. , & Mullins, C.D. (2006). Cost-of-illness studies: A review of current methods . Pharmacoeconomics, 24(9), 869-890.

American Heart Association and American Stroke Association. (2006). Heart disease and stroke statistics—2006 update. Circulation, 113, e85-e151.

Berk, M.L. , & Monheit, A.C. (2001, March/ April). The concentration of health care expenditures, revisited. Health Affairs, 233-241. Centers for Medicare & Medicaid Services. (2006a). Medicaid program overview. Retrieved December 18, 2006, from http://www.cms.hhs.gov/MedicaidGenInfo/

Centers for Medicare & Medicaid Services. ( 2006b). Medicare program overview. Retrieved December 18, 2006, from http://www.cms.hhs.gov/MedicareGenInfo/

Centers for Medicare & Medicaid Services. ( 2006c). Prescription drug coverage overview. Retrieved December 18, 2006, from http://www.cms.hhs.gov/PrescriptionDrugCovGenIn/

Cohen, J.W. , & Krauss, N.A. (2003, March/ April). Spending and service use among people with the 15 most costly medical conditions, 1997. Health Affairs , 129-138.

Cohen, J.W. , Monheit, A.C. , Beauregard, K.M. , Cohen, S.B. , Lefkowitz, D.C. , Potter, D.E. , et al. (1996/1997, Winter/Spring). The Medical Expenditure Panel Survey: A national health information resource. Inquiry, 373-389.

Druss, B.G. , Marcus, S.C. , Olfson, M. , Tanielian, T. , Elinson, L. , & Pincus, H.A. (2001, November/December). Comparing the national economic burden of five chronic conditions. Health Affairs, 233-241.

Haber, S. , Gilman, B. , Tangka, F. , Orenstein, D. , Nwaise, I. , & Crespin, D. (2006). Estimating state costs for chronic diseases using Medicaid data. In review.

10.

Hoffman, C. , Rice, D. , & Sung, H.Y. (1996). Persons with chronic conditions: Their prevalence and costs. JAMA, 276(18), 1473-1479. Manning, W.G. , & Mullahy , J. (2001). Estimating log models: To transform or not to transform? Journal of Health Economics, 20, 461-494.

11.

Sullivan P. , & Ghushchyan V. (2006). Preference-based EQ-5D index scores for chronic conditions in the U.S. Medical Decision Making, 26, 410-420.

12.

Trogdon, J.G. , Finkelstein, E.A. , & Hoerger, T.J. (2006). Use of econometric models to estimate disease-specific shares of medical expenditures. In review.

13.

U.S. Census Bureau, Housing and Household Economic Statistics Division. (2007). Poverty thresholds. Retrieved January 17, 2007, from http://www.census.gov/hhes/www./poverty/threshld.html

14.

U.S. Department of Labor, Bureau of Labor Statistics. (2006). Consumer price indexes. Retrieved December 18, 2006, from http://www.bls.gov/cpi/home.htm